Figures extracted from the demerged Orion's financial information for the review

Oriola-KD Corporation    Stock Exchange Release,   7 August 2006 at 2p.m.

Orion Corporation demerged into two new listed companies, Orion Corporation and
Oriola-KD Corporation on 1 July 2006. The Oriola-KD Group was formed from the
demerged Orion Group's Wholesale and Distribution Division companies Oriola Oy
and Kronans Droghandel AB with their subsidiaries. The implementation of Orion
Corporation's demerger was entered in the Trade Register on 1 July 2006. On the
same date, the demerging Orion Corporation was dissolved and the new companies
arising in the demerger, Oriola-KD Corporation and Orion Corporation, were
entered in the Trade Register. The figures for the period presented in this
stock exchange release are the figures of Orion Corporation's Wholesale and
Distribution Division, which have been extracted from the financial information
of the demerged Orion Corporation. Hereinafter the name Oriola-KD is used in
referring to the Wholesale and Distribution Division. The figures for
Oriola-KD's period have been prepared in accordance with the recognition and
valuation principles of the IFRS standards. The financial information is
presented in accordance with the accounting policies applied in the Listing
Particulars published in June 2006, and they are unaudited. 

Key figures

- Invoicing in the period was EUR 1,174.1 million (1-6/2005: EUR 1,204.5
million) and net sales were EUR 671.9 million (1-6/2005: EUR 665.9 million). 
- Operating profit excluding one-off items was EUR 9.8 million (1-6/2005: EUR
12.1 million). 
- Operating profit including one-off items was EUR 5.3 million (1-6/2005: EUR
12.1 million). 
- Cash flow after investing activities was EUR 2.7 million (1-6/2005: EUR 2.7
million). 
- Earnings per share were EUR 0.03 (1-6/2005: EUR 0.06).

President and CEO Eero Hautaniemi: "Oriola-KD's invoicing in the first half of
2006 was nearly at the level of the previous year's comparable invoicing, and
operating profit was lower than the comparable operating profit in 2005. The
lower and unsatisfactory operating profit is mainly due to the heavy
competitive situation and the slow growth of the pharmaceutical market in
Finland, as well as to the one-off items related to the demerger and the
operational rearrangements being implemented in Oriola-KD. The cost efficiency
measures started in the first part of the year are progressing according to
plan. The long-term fundamentals in the healthcare market are favourable. Our
strong cash flow and balance sheet will enable the company to develop in line
with its growth strategy." 

Future outlook

The Oriola-KD Group's outlook for 2006 is based on external market forecasts,
agreements with principals, cumulative orders and management's estimates. 

The long-term fundamentals for the healthcare market are favourable.
International market research institute IMS Health predicts the pharmaceutical
market growth in 2006 in Finland to be flat and the Swedish market to grow by
4-5 per cent. The Oriola-KD Group estimates that the longer term pharmaceutical
market will grow by about 3-5 per cent in Finland and Sweden over the next few
years, which is in line with the average growth rate of these markets. 

The overall objective of the cost efficiency measures that were launched in the
early part of 2006 is to achieve total savings of about five million euros
annually in the Group's operations in Finland and Sweden, with full impact as
of 2007. The one-off items of the cost efficiency measures are estimated to be
about EUR 3 million and they will occur in 2006. 

The Oriola-KD Group estimates that the market for healthcare and dental
equipment and supplies will grow by more than 5 per cent in Finland and Sweden
in 2006. The Oriola-KD Group estimates that the growth in its sales of
healthcare equipment and supplies will grow faster than the market. The growth
of dental trade is expected to be slower than the market. Invoicing for the
healthcare logistics services in Sweden is estimated to be at the previous
year's level. 

Oriola-KD Group's invoicing in 2006 is forecast to be nearly at the level of
the previous year's comparable invoicing. Operating profit for 2006 is forecast
to be lower than the previous year's comparable operating profit, owing mainly
to the tight competitive situation within pharmaceutical distribution and
trade, and the slow growth in Finland's pharmaceutical market in the early part
of the year as well as to one-off expenses for the demerger and the
reorganisation of functions. 

Espoo, 7 August 2006

Oriola-KD Corporation's Board of Directors

Oriola-KD Corporation

Eero Hautaniemi         Kimmo Virtanen
President and CEO     CFO

For additional information, contact:

Eero Hautaniemi
President and CEO
tel. +358 10 429 2109
email: eero.hautaniemi@oriola.com

Kimmo Virtanen
CFO
tel. +358 10 429 2069
email: kimmo.virtanen@oriola.com

Pellervo Hämäläinen
Vice President, Communications and IR
tel. +358 10 429 2497
email: pellervo.hamalainen@oriola.com

Distribution
Helsinki Stock Exchange
Principal media

Published by:
Oriola-KD Corporation
Corporate Communications
Harmaaparrankuja 1
FI-02200 Espoo
www.oriola-kd.com

The full report including tables can be dowloaded from the link below:

Stock Exchange Release: Financial Information 1-6 2006

The presentation material can be downloaded from the link below:

Presentation: Financial Information 1-6 2006